Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hepatitis Foundation International (HFI) is a non-profit organization dedicated to the eradication of viral hepatitis and the promotion of liver health. Established in 1994, the foundation provides comprehensive education, advocacy, and support services for patients, healthcare professionals, and the general public. HFI's initiatives include public awareness campaigns, screening programs, and the operation of a national hotline to assist individuals in navigating the healthcare system. The organization also focuses on related conditions such as fatty liver disease and liver cancer, working to reduce the global burden of liver-related chronic diseases through prevention and early detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hepatitis Foundation International.